Concorde Asset Management’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$97.3K Sell
19,160
-1,160
-6% -$5.44K 0.06% 148
2026
Q1
$72.1K Sell
20,320
-7,740
-28% -$31.7K 0.04% 206
2025
Q4
$132K Sell
28,060
-8,130
-22% -$36.2K 0.05% 232
2025
Q3
$173K Buy
+36,190
New +$143K 0.07% 214
2025
Q1
$175K Sell
66,972
-13,977
-17% -$45.1K 0.09% 165
2024
Q4
$308K Sell
80,949
-30,017
-27% -$162K 0.16% 119
2024
Q3
$796K Sell
110,966
-3,470
-3% -$24.7K 0.45% 37
2024
Q2
$839K Sell
114,436
-9,830
-8% -$85.8K 0.52% 30
2024
Q1
$1.24M Sell
124,266
-102,200
-45% -$895K 0.85% 22
2023
Q4
$873K Buy
226,466
+106,506
+89% +$708K 0.59% 23
2023
Q3
$952K Buy
119,960
+69,038
+136% +$435K 0.86% 23
2023
Q2
$282K Hold
50,922
0.26% 81
2023
Q1
$290K Sell
50,922
-800
-2% -$5.29K 0.34% 54
2022
Q4
$362K Buy
51,722
+36,757
+246% +$378K 0.32% 75
2022
Q3
$105K Sell
14,965
-1,780
-11% -$20.5K 0.12% 132
2022
Q2
$173K Sell
16,745
-400
-2% -$5.94K 0.26% 98
2022
Q1
$358K Buy
17,145
+170
+1% +$3.71K 0.24% 94
2021
Q4
$434K Buy
16,975
+960
+6% +$26.5K 0.26% 108
2021
Q3
$505K Buy
16,015
+4,055
+34% +$140K 0.29% 112
2021
Q2
$479K Buy
11,960
+8,050
+206% +$327K 0.27% 96
2021
Q1
$355K Buy
+3,910
New +$180K 0.2% 126

Other funds holding MSOS

Concorde Asset Management's MSOS Position: Q2 2026 in Review

Concorde Asset Management reduced its AdvisorShares Pure US Cannabis ETF (MSOS) stake by 5.7% in Q2 2026, selling an estimated $5.44K and leaving 19,160 shares worth $97.3K. The position accounts for 0.06% of the portfolio, ranked #148.

Concorde Asset Management first reported a position in MSOS in Q1 2021 and has held it in 21 quarters since. The position peaked at $1.24M in Q1 2024. 169 funds tracked by Wall St. Rank hold MSOS as of Q2 2026.

  • Concorde Asset Management held 19,160 shares of AdvisorShares Pure US Cannabis ETF worth $97.3K as of Q2 2026.
  • Concorde Asset Management sold 1,160 AdvisorShares Pure US Cannabis ETF shares in Q2 2026, an estimated $5.44K.
  • AdvisorShares Pure US Cannabis ETF made up 0.06% of Concorde Asset Management's portfolio in Q2 2026, its #148 holding.
  • Concorde Asset Management first reported a position in AdvisorShares Pure US Cannabis ETF in Q1 2021 and has held it in 21 quarters since.
  • Concorde Asset Management's AdvisorShares Pure US Cannabis ETF position peaked at $1.24M in Q1 2024.
  • 169 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q2 2026.

Based on Concorde Asset Management's 13F filing for Q2 2026, filed 18 Aug 2026.